OPTI:Optibiotix fell 31% in my cheapest holding and 3% in my most expensive holding as it drifts on no news. That accounted for around £7,000 of the drop, with the rest coming from small drops everywhere else.
I nearly didn't bother with Share of the Week as nothing reached the normal 5% threshold, but TRX:Tissue Regenix did climb 3% so I suppose can have the award. It's still 62% down so not a great investment.
Here's the ISA and shares portfolio after week 6 of year 9.
| Weekly Change | |||
| Cash | £152.28 | +£0 | |
| Portfolio cost | £93,364.33 | +£0 | |
| Portfolio sell value (bid price-commission) | £47,047.78 | (-49.6%) | -£3,600.14 |
| Potential profits | £2,021.52 | -£623.17 | |
| Yr 9 Dividends | £0 | +£0 | |
| Yr 9 Interest | £0.47 | +£0 | |
| Yr 9 Profit from sales | £0 | +£0 | |
| Yr 9 proj avg monthly profit | -£3.87 | (-0.1%) | +£0.78 |
| Total Dividends | £11,911.43 | +£0 | |
| Total Interest | £2.40 | +£0 | |
| Total Profit from sales | £17,298.53 | +£0 | |
| Average monthly cash profit | £296.03 | (5.5%) | -£0.70 |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Compound performance | 44% | +0% |
After the meteoric rise, we now have the gradual decline.
I guess I should be celebrating that the trend line is pointing upwards for the first time in years, but it won't be for long if we drop to meet it.
The SIPP looks like this after week 406 overall and week 42 of year 8.
| Weekly Change | ||||
| Cash | £152.69 | -£164.95 | ||
| Portfolio cost | £96,537.55 | +£289.95 | ||
| Portfolio sell value (bid price - commission) | £51,798.22 | (-46.3%) | -£3,962.98 | |
| Potential profits | £3,424.86 | -£709.31 | ||
| Yr 8 Dividends | £253.36 | +£0 | ||
| Yr 8 Interest | £3.98 | +£0 | ||
| Yr 8 Profit from sales | -£9,597.85 | +£0 | ||
| Yr 8 proj avg monthly profit | -£974.72 | (-17.8%) | +£23.78 | |
| Total Dividends | £14,396.14 | +£0 | ||
| Total Interest | £4.23 | +£0 | ||
| Total Profit from sales | £10,835.90 | +£0 | ||
| Average monthly cash profit | £257.58 | (4.7%) | -£0.63 | |
| (Sold stocks profit + Dividends - Fees / Months) | ||||
| Compound performance | 37% | +0% |
I had £125 premium bond win, so added it to various tax rebates and dividends to buy 4,058 shares in JLP:Jubilee Metals while they are depressed. I got them at 6.9p costing £289.95 which is less than my usual minimum of £500, but I didn't have a spare £200 to top it up. It brings my average price in my AJ Bell SIPP down from 11.9p to 10.9p, but this holding is still 39% down.
Meanwhile same story as the ISA for big drops in both value and potential profits.
Same shape as the ISA, in fact looks like a steeper drop
The trend line is slightly steeper upwards, but we're not far above it.
The trading account looks like this after week 372 overall and week 8 of year 8.
| Weekly Change | |||
| Cash | £273.24 | +£0 | |
| Portfolio cost | £1,794.51 | +£0 | |
| Portfolio sell value (bid price - commission) | £1,123.02 | (-37.4%) | -£3.55 |
| Potential profits | £0 | +£0 | |
| Year 8 Dividends | £0 | +£0 | |
| Year 8 Interest | £0 | +£0 | |
| Year 8 Profit | £283.99 | +£0 | |
| Yr 8 proj avg monthly profit | £153.83 | (+102.9%) | -£21.97 |
| Dividends | £60.10 | +£0 | |
| Interest | £0.03 | +£0 | |
| Profit from sales | -£646.70 | +£0 | |
| Average monthly cash profit | -£6.83 | (-4.6%) | +£0.02 |
| (Sold stocks profit + Dividends - Fees / Months) |
BARC:Barclays dropped a tiny amount so I lost £3 in value. Nothing else to say.
At least this one has flattened off after the steep upward rise because I sold OPTI:Optibiotix around its peak.
Below the trend line now. Good news from JLP:Jubilee Metals is what's needed to get things moving.
It's all down to news, or the lack of it. All my microbiome shares are drifting, as is JLP:Jubilee Metals despite making big profits at low metal prices. Hopefully now summer holidays are over we'll get some contracts signed.
No comments:
Post a Comment